vs
Niagen Bioscience, Inc.（NAGE）与Tilray Brands, Inc.（TLRY）财务数据对比。点击上方公司名可切换其他公司
Tilray Brands, Inc.的季度营收约是Niagen Bioscience, Inc.的6.4倍（$217.5M vs $33.8M）。Niagen Bioscience, Inc.净利率更高（12.2% vs -20.7%，领先32.9%）。Niagen Bioscience, Inc.同比增速更快（16.2% vs 3.1%）。过去两年Niagen Bioscience, Inc.的营收复合增速更高（23.6% vs 7.5%）
Niagen Bioscience（原名为ChromaDex）是一家成立于1999年，总部位于加利福尼亚州洛杉矶的生物科技公司。公司业务涵盖标准品、膳食补充剂以及原料技术开发多个领域，目前在纳斯达克挂牌上市。
Tilray Brands, Inc.是一家美国企业，主营医药、大麻生活方式产品以及包装消费品业务，公司注册于美国，总部坐落于纽约。该公司在加拿大、澳大利亚、新西兰、拉美地区均开展业务，同时在德国和葡萄牙拥有大麻种植基地。
NAGE vs TLRY — 直观对比
营收规模更大
TLRY
是对方的6.4倍
$33.8M
营收增速更快
NAGE
高出13.1%
3.1%
净利率更高
NAGE
高出32.9%
-20.7%
两年增速更快
NAGE
近两年复合增速
7.5%
损益表 — Q4 2025 vs Q2 2026
| 指标 | | |
|---|---|---|
| 营收 | $33.8M | $217.5M |
| 净利润 | $4.1M | $-44.9M |
| 毛利率 | 64.1% | 26.4% |
| 营业利润率 | 12.1% | -10.2% |
| 净利率 | 12.2% | -20.7% |
| 营收同比 | 16.2% | 3.1% |
| 净利润同比 | -42.4% | 47.4% |
| 每股收益（稀释后） | $0.05 | $-0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NAGETLRY
| Q4 25 | $33.8M | $217.5M | ||
| Q3 25 | $34.0M | $209.5M | ||
| Q2 25 | $31.1M | $224.5M | ||
| Q1 25 | $30.5M | $185.8M | ||
| Q4 24 | $29.1M | $210.9M | ||
| Q3 24 | $25.6M | $200.0M | ||
| Q2 24 | $22.7M | $229.9M | ||
| Q1 24 | $22.2M | $188.3M |
净利润NAGETLRY
| Q4 25 | $4.1M | $-44.9M | ||
| Q3 25 | $4.6M | $-322.0K | ||
| Q2 25 | $3.6M | $-1.3B | ||
| Q1 25 | $5.1M | $-789.4M | ||
| Q4 24 | $7.2M | $-85.3M | ||
| Q3 24 | $1.9M | $-39.2M | ||
| Q2 24 | $-15.0K | $-31.7M | ||
| Q1 24 | $-492.0K | $-92.7M |
毛利率NAGETLRY
| Q4 25 | 64.1% | 26.4% | ||
| Q3 25 | 64.5% | 27.4% | ||
| Q2 25 | 65.0% | 30.1% | ||
| Q1 25 | 63.4% | 28.0% | ||
| Q4 24 | 62.5% | 29.0% | ||
| Q3 24 | 63.5% | 29.8% | ||
| Q2 24 | 60.2% | 35.8% | ||
| Q1 24 | 60.7% | 26.2% |
营业利润率NAGETLRY
| Q4 25 | 12.1% | -10.2% | ||
| Q3 25 | 12.5% | 1.0% | ||
| Q2 25 | 10.2% | -643.1% | ||
| Q1 25 | 15.7% | -409.0% | ||
| Q4 24 | 24.4% | -20.0% | ||
| Q3 24 | 6.3% | -18.3% | ||
| Q2 24 | -1.1% | -7.2% | ||
| Q1 24 | -3.3% | -43.6% |
净利率NAGETLRY
| Q4 25 | 12.2% | -20.7% | ||
| Q3 25 | 13.5% | -0.2% | ||
| Q2 25 | 11.6% | -566.9% | ||
| Q1 25 | 16.6% | -424.9% | ||
| Q4 24 | 24.6% | -40.5% | ||
| Q3 24 | 7.3% | -19.6% | ||
| Q2 24 | -0.1% | -13.8% | ||
| Q1 24 | -2.2% | -49.2% |
每股收益（稀释后）NAGETLRY
| Q4 25 | $0.05 | $-0.41 | ||
| Q3 25 | $0.05 | $0.00 | ||
| Q2 25 | $0.04 | $7.26 | ||
| Q1 25 | $0.06 | $-8.69 | ||
| Q4 24 | $0.10 | $-0.99 | ||
| Q3 24 | $0.02 | $-0.04 | ||
| Q2 24 | $0.00 | $-0.04 | ||
| Q1 24 | $-0.01 | $-0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $291.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $76.5M | $1.6B |
| 总资产 | $106.4M | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NAGETLRY
| Q4 25 | — | $291.6M | ||
| Q3 25 | $64.1M | $264.8M | ||
| Q2 25 | $60.3M | $256.4M | ||
| Q1 25 | $55.5M | — | ||
| Q4 24 | $44.5M | $252.2M | ||
| Q3 24 | $32.2M | $280.1M | ||
| Q2 24 | $27.7M | $260.5M | ||
| Q1 24 | $27.4M | $225.9M |
股东权益NAGETLRY
| Q4 25 | $76.5M | $1.6B | ||
| Q3 25 | $70.7M | $1.5B | ||
| Q2 25 | $64.2M | $1.5B | ||
| Q1 25 | $55.3M | $2.7B | ||
| Q4 24 | $46.1M | $3.5B | ||
| Q3 24 | $34.4M | $3.5B | ||
| Q2 24 | $30.7M | $3.4B | ||
| Q1 24 | $29.0M | $3.4B |
总资产NAGETLRY
| Q4 25 | $106.4M | $2.1B | ||
| Q3 25 | $98.1M | $2.1B | ||
| Q2 25 | $91.5M | $2.1B | ||
| Q1 25 | $81.3M | — | ||
| Q4 24 | $68.3M | $4.2B | ||
| Q3 24 | $56.5M | $4.3B | ||
| Q2 24 | $54.0M | $4.2B | ||
| Q1 24 | $54.1M | $4.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $679.0K | $-8.5M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 0.16× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流NAGETLRY
| Q4 25 | $679.0K | $-8.5M | ||
| Q3 25 | $3.7M | $-1.3M | ||
| Q2 25 | $1.3M | $-12.8M | ||
| Q1 25 | $7.9M | $-5.8M | ||
| Q4 24 | $8.6M | $-40.7M | ||
| Q3 24 | $3.5M | $-35.3M | ||
| Q2 24 | $-264.0K | $30.7M | ||
| Q1 24 | $295.0K | $-15.4M |
自由现金流NAGETLRY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-19.1M | ||
| Q1 25 | — | $-20.2M | ||
| Q4 24 | — | $-46.2M | ||
| Q3 24 | — | $-42.0M | ||
| Q2 24 | — | $21.0M | ||
| Q1 24 | — | $-24.9M |
自由现金流率NAGETLRY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -8.5% | ||
| Q1 25 | — | -10.9% | ||
| Q4 24 | — | -21.9% | ||
| Q3 24 | — | -21.0% | ||
| Q2 24 | — | 9.1% | ||
| Q1 24 | — | -13.2% |
资本支出强度NAGETLRY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | — | 7.8% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 3.4% | ||
| Q2 24 | — | 4.2% | ||
| Q1 24 | — | 5.1% |
现金转化率NAGETLRY
| Q4 25 | 0.16× | — | ||
| Q3 25 | 0.81× | — | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 1.56× | — | ||
| Q4 24 | 1.20× | — | ||
| Q3 24 | 1.86× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NAGE
| TRUNIAGEN Consumer Product | $27.5M | 81% |
| Ingredients Segment | $5.7M | 17% |
| Other | $694.0K | 2% |
TLRY
| Adultuse Cannabis Products | $62.4M | 29% |
| Other | $59.2M | 27% |
| Beverage Alcohol Business | $53.6M | 25% |
| International Cannabis Products | $20.2M | 9% |
| Wellness Business | $14.6M | 7% |
| Medical Cannabis Products | $6.2M | 3% |
| Wholesale Cannabis Products | $1.3M | 1% |
